Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea

NCT03572972 · clinicaltrials.gov ↗

COMPLETED

Status

64684

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Apixaban
DRUG: Dabigatran
DRUG: Rivaroxaban
DRUG: warfarin
DRUG: Antiplatelets

Sponsor

Pfizer